Amarin reported $0 in Loan Capital for its fiscal quarter ending in March of 2025.


Loan Capital Change Date
AbbVie USD 64.53B 4.19B Mar/2025
Alnylam Pharmaceuticals USD 1.03B 956K Jun/2025
Amarin USD 0 0 Mar/2025
AstraZeneca USD 25.99B 1.9B Jun/2025
DBV Technologies USD 0 0 Mar/2025
GlaxoSmithKline GBP 15.3B 1.17B Jun/2025
Halozyme Therapeutics USD 1.51B 1.65M Jun/2025
Ionis Pharmaceuticals USD 625.49M 625.22M Jun/2025
Neurocrine Biosciences USD 0 0 Dec/2024
Novartis USD 24.06B 2.4B Jun/2025